| Source: |
| Type: |
| Drug dosage vs efficacy, and actual dosage number of research papers. |
| 6936- | MF, | Ex, | Pulsed electromagnetic field with or without exercise therapy in the treatment of benign prostatic hyperplasia |
| - | Trial, | BPH, | NA |
| 6941- | MF, | Ex, | The effects of pulsed electromagnetic field therapy on muscle strength and pain in patients with end-stage knee osteoarthritis: a randomized controlled trial |
| - | Trial, | Arthritis, | NA |
| 4571- | MF, | Magnetic Fields and Reactive Oxygen Species |
| - | Review, | Var, | NA |
| 4349- | MF, | Long-term effect of full-body pulsed electromagnetic field and exercise protocol in the treatment of men with osteopenia or osteoporosis: A randomized placebo-controlled trial |
| - | Trial, | ostP, | NA |
| 4355- | MF, | Ambient and supplemental magnetic fields promote myogenesis via a TRPC1-mitochondrial axis: evidence of a magnetic mitohormetic mechanism |
| - | in-vitro, | Nor, | C2C12 |
| - | in-vitro, | BC, | 4T1 | - | in-vitro, | BC, | MCF7 |
| 491- | MF, | Pre-exposure of neuroblastoma cell line to pulsed electromagnetic field prevents H2 O2 -induced ROS production by increasing MnSOD activity |
| - | in-vitro, | neuroblastoma, | SH-SY5Y |
| 192- | MF, | The use of magnetic fields in treatment of patients with rheumatoid arthritis. Review of the literature |
| - | Review, | Arthritis, | NA |
| 4015- | MF, | Evaluation of the PTEN and circRNA-CDR1as Gene Expression Changes in Gastric Cancer and Normal Cell Lines Following the Exposure to Weak and Moderate 50 Hz Electromagnetic Fields |
| - | in-vitro, | GC, | AGS | - | in-vitro, | Nor, | HU02 |
| 3740- | MF, | Gamma rhythm low field magnetic stimulation alleviates neuropathologic changes and rescues memory and cognitive impairments in a mouse model of Alzheimer's disease |
| - | in-vivo, | AD, | NA |
| - | Study, | Stroke, | NA |
| 4095- | MF, | Frequency-tuned electromagnetic field therapy improves post-stroke motor function: A pilot randomized controlled trial |
| - | Trial, | Stroke, | NA |
| 4097- | MF, | Theta Frequency Electromagnetic Stimulation Enhances Functional Recovery After Stroke |
| - | Trial, | Stroke, | NA |
| 4119- | MF, | Therapeutic potential and mechanisms of repetitive transcranial magnetic stimulation in Alzheimer’s disease: a literature review |
| - | Review, | AD, | NA |
| 4096- | MF, | Extremely Low‐Frequency and Low‐Intensity Electromagnetic Field Technology (ELF‐EMF) Sculpts Microtubules |
| - | in-vitro, | AD, | NA |
| 4098- | MF, | Extremely low frequency electromagnetic field (ELF-EMF) reduces oxidative stress and improves functional and psychological status in ischemic stroke patients |
| - | Trial, | Stroke, | NA |
| 4102- | MF, | Modulation of antioxidant enzyme gene expression by extremely low frequency electromagnetic field in post-stroke patients |
| - | Human, | Stroke, | NA |
| 4103- | MF, | Comparing the Effects of Long-term Exposure to Extremely Low-frequency Electromagnetic Fields With Different Values on Learning, Memory, Anxiety, and β-amyloid Deposition in Adult Rats |
| - | in-vivo, | Nor, | NA |
| 4111- | MF, | Coupling of pulsed electromagnetic fields (PEMF) therapy to molecular grounds of the cell |
| - | Review, | Arthritis, | NA |
| 4148- | MF, | Increase in Blood Levels of Growth Factors Involved in the Neuroplasticity Process by Using an Extremely Low Frequency Electromagnetic Field in Post-stroke Patients |
| - | Human, | Stroke, | NA |
| 3473- | MF, | Therapeutic use of pulsed electromagnetic field therapy reduces prostate volume and lower urinary tract symptoms in benign prostatic hyperplasia |
| - | Human, | BPH, | NA |
| 8480- | MFrot, | Neuroprotective effect of RMF in a mouse model of sporadic Parkinson's disease |
| - | in-vivo, | Park, | NA |
| 8482- | MFrot, | Polyhedral magnetic nanoparticles induce apoptosis in gastric cancer stem cells and suppressing tumor growth through magnetic force generation |
| - | vitro+vivo, | GC, | NA |
| 8479- | MFrot, | doxoR, | Dual-targeting by rotating magnetic field-driven superparamagnetic bionic nanorobots for enhanced triple-negative breast cancer therapy |
| - | vitro+vivo, | BC, | 4T1 |
| 8478- | MFrot, | Dynamic magneto-mechanical force in lysosomes induces durable macrophage repolarization for antitumor immunity |
| - | vitro+vivo, | Lung, | NA |
| 8477- | MFrot, | Urchin-like magnetic nanoparticles loaded with type X collagen siRNA and Stattic to treat triple negative breast cancer under rotating magnetic field like an "enchanted micro-scalpel" |
| - | Study, | BC, | NA |
| 8476- | MFrot, | Actin-Targeted Magnetic Nanomotors Mechanically Modulate the Tumor Mechanical Microenvironment for Cancer Treatment |
| - | in-vitro, | Var, | NA |
| 5242- | MFrot, | Rotating magnetic field downregulating type XI collagen to suppress triple-negative breast cancer metastasis by inactivating the ITGB1/FAK/YAP signaling pathway |
| - | in-vitro, | BC, | NA |
| 5535- | MFrot, | Spatiotemporal magnetic fields enhance cytosolic Ca2+ levels and induce actin polymerization via activation of voltage-gated sodium channels in skeletal muscle cells |
| - | in-vitro, | Nor, | NA |
| 7388- | MFrot, | Magnetoporation and magnetolysis of cancer cells via carbon nanotubes induced by rotating magnetic fields |
| - | in-vitro, | BC, | MCF7 |
| 187- | MFrot, | MF, | Method for noninvasive whole-body stimulation with spinning oscillating magnetic fields and its safety in mice |
| - | in-vivo, | GBM, | NA |
| 185- | MFrot, | MF, | Case Report: End-Stage Recurrent Glioblastoma Treated With a New Noninvasive Non-Contact Oncomagnetic Device |
| - | Human, | GBM, | NA |
| 184- | MFrot, | MF, | Rotating Magnetic Fields Inhibit Mitochondrial Respiration, Promote Oxidative Stress and Produce Loss of Mitochondrial Integrity in Cancer Cells |
| - | in-vitro, | GBM, | GBM |
| 516- | MFrot, | immuno, | MF, | Anti-tumor effect of innovative tumor treatment device OM-100 through enhancing anti-PD-1 immunotherapy in glioblastoma growth |
| - | vitro+vivo, | GBM, | U87MG |
| 1737- | MFrot, | Fe, | MF, | Feature Matching of Microsecond-Pulsed Magnetic Fields Combined with Fe3O4 Particles for Killing A375 Melanoma Cells |
| - | in-vitro, | MB, | A375 |
| 4569- | MFrot, | Case Report: A new noninvasive device-based treatment of a mesencephalic H3 K27M glioma |
| - | Case Report, | GBM, | NA |
| 8457- | Mg, | The effects of magnesium L-threonate (Magtein®) on cognitive performance and sleep quality in adults: a randomised, double-blind, placebo-controlled trial |
| - | Trial, | AD, | NA |
| 8464- | Mg, | Cisplatin, | Efficacy of Prophylactic Magnesium Therapy for the Prevention of Cisplatin-Induced Renal Injury: A Meta-Analysis |
| - | Review, | Var, | NA |
| - | Trial, | Nor, | NA |
| 8473- | Mg, | Oral magnesium supplementation decreases C-reactive protein levels in subjects with prediabetes and hypomagnesemia: a clinical randomized double-blind placebo-controlled trial |
| - | Trial, | Nor, | NA |
| 8475- | Mg, | Magnesium supplementation improves indicators of low magnesium status and inflammatory stress in adults older than 51 years with poor quality sleep |
| - | Trial, | Nor, | NA |
| 1776- | MLT, | Therapeutic strategies of melatonin in cancer patients: a systematic review and meta-analysis |
| - | Review, | Var, | NA |
| 1778- | MLT, | Melatonin: a well-documented antioxidant with conditional pro-oxidant actions |
| - | Review, | Var, | NA | - | Review, | AD, | NA |
| 1779- | MLT, | Therapeutic Potential of Melatonin Counteracting Chemotherapy-Induced Toxicity in Breast Cancer Patients: A Systematic Review |
| - | Review, | BC, | NA |
| 1782- | MLT, | Melatonin in Cancer Treatment: Current Knowledge and Future Opportunities |
| - | Review, | Var, | NA |
| 1783- | MLT, | The efficacy and safety of melatonin in concurrent chemotherapy or radiotherapy for solid tumors: a meta-analysis of randomized controlled trials |
| - | Review, | Var, | NA |
| 8657- | MLT, | Melatonin in Alzheimer's Disease: Literature Review and Therapeutic Trials |
| - | Review, | AD, | NA |
| 8659- | MLT, | Cisplatin, | Melatonin Sensitizes OVCAR-3 Cells to Cisplatin through Suppression of PI3K/Akt Pathway |
| - | in-vitro, | Ovarian, | OVCAR-3 |
| 8660- | MLT, | Unraveling the impact of melatonin treatment: Oxidative stress, metabolic responses, and morphological changes in HuH7.5 hepatocellular carcinoma cells |
| - | in-vitro, | CCA, | HuH28 |
| 8672- | MLT, | Glioblastoma and Melatonin’s Effects: A Narrative Review |
| - | Review, | GBM, | NA |
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1114 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid